<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01141829</url>
  </required_header>
  <id_info>
    <org_study_id>NADPHPM2010</org_study_id>
    <nct_id>NCT01141829</nct_id>
  </id_info>
  <brief_title>NADPH Oxidase Polymorphisms in Obstructive Sleep Apnea Syndrome (OSAS)</brief_title>
  <official_title>NADPH Oxidase p22phox Polymorphisms and Oxidative Stress in Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Research Center for Respiratory Diseases</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sociedad Española de Neumología y Cirugía Torácica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive Sleep Apnea (OSA) is associated with increased oxidative stress. The major
      sources of Reactive Oxygen Species (ROS) in the vasculature are the NADPH oxidases. Several
      polymorphisms related to NADPH oxidase expression or NADPH oxidase activity has been
      identified. The investigators are going to compare the distribution of the allelic
      frequencies of A-930G and C242T polymorphisms and their possible relationship with the levels
      of 8-isoprostanes as a marker of oxidative stress in patients with OSA and in a control group
      without OSA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DESIGN: CASE-CONTROL STUDY METHODS: We are going to determine the A-930G and C242T p22phox
      genotypes in patients with OSA and healthy subjects recruited from sleep unit of Son Dureta
      University Hospital, (Palma de Mallorca, Spain). 8-Isoprostane is going to be measured as an
      oxidative stress marker with an 8-isoprostane EIA kit (Cayman Chemicals Company, USA) in
      plasma samples.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <condition>Sleep Apnea Syndrome</condition>
  <condition>Oxidative Stress</condition>
  <condition>Single Nucleotide Polymorphism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with OSAS defined by an apnea hypopnea index (AHI)&gt;10 h-1 will be included in the
        study along with control subjects without OSAS. Participants were consequently studied at
        the sleep unit of Hospital Universitario Son Dureta, (Palma de Mallorca, Spain).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:Polyysomnografic study with Apnoea/Hypoapnoea Index higher to 10 in
        patients and lower in controls.

        Exclusion Criteria:

          -  chronic obstructive pulmonary disease, liver cirrhosis, thyroid dysfunction,
             rheumatoid arthritis, chronic renal failure and/or psychiatric disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mónica de La Peña, MD</last_name>
    <phone>0034971175112</phone>
    <email>monica.delapena@ssib.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Piérola, Biologist</last_name>
      <phone>0034666149639</phone>
      <email>javier.pierola@ssib.es</email>
    </contact>
    <investigator>
      <last_name>Javier Piérola, Biologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2010</study_first_submitted>
  <study_first_submitted_qc>June 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2010</study_first_posted>
  <last_update_submitted>June 10, 2010</last_update_submitted>
  <last_update_submitted_qc>June 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Javier Piérola Lopetegui</name_title>
    <organization>Hospital Universitario Son Dureta</organization>
  </responsible_party>
  <keyword>NADPH oxidase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

